- Research Fellowship - Baylor University Medical Center (2006-2007), Hepatology
- Fellowship - Washington University School of Medicine (2001-2004), Gastroenterology
- Internship/Residency - Emory University Hospital (1997-2000), Internal Medicine
- Medical School - Wake Forest University School of Medicine (1993-1997)
Lafaine Grant, M.D.
Clinical Director of Hepatology, Parkland Memorial Hospital
- Internal Medicine - Digestive and Liver Diseases
- Liver Transplant Evaluations
- Liver Transplant Medicine
New Patient Appointment Accepting Virtual Visits or 214-645-0595
Biography
Lafaine Grant, M.D., is an Associate Professor in the UT Southwestern Medical Center’s Department of Internal Medicine.
Dr. Grant earned her medical degree at Wake Forest University School of Medicine. She completed her residency in internal medicine at Emory University Hospital and a fellowship in gastroenterology at the Washington University School of Medicine. She then completed an advanced fellowship in hepatology at Baylor University Medical Center. She joined the staff of UT Southwestern in 2007.
Dr. Grant is a member of the American Medical Association, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases.
Meet Dr. Grant
Liver Disease Specialist in Dallas
As a transplant hepatologist with specialized training in both liver disease and liver transplantation, Lafaine Grant, M.D., treats patients with all types of liver disease.
Dr. Grant joined UT Southwestern Medical Center in 2007 to help form the Liver Transplant Program, where she works with people who are candidates for – or who have already received – a liver transplant.
An Evolving Field
Dr. Grant says that the certain types of liver disease are becoming less of a problem for patients – for example, hepatitis C, which is now highly treatable – while others are growing much more problematic.
“My patient population reflects the general population at large,” she explains, “and the majority have liver injury from alcohol or viral hepatitis. There are also a good number of patients who have autoimmune liver disease or drug-induced liver injury, and an increasing number are being seen for fatty liver.”
Most liver diseases require careful management or treatment in order to prevent serious complications, Dr. Grant says.
“Chronic liver disease can cause extensive scarring of the liver, which is what we call cirrhosis,” she says. “Any patient with cirrhosis can then have complications of cirrhosis, and when that occurs, the patient is considered for liver transplant.”
For patients who do require a transplant, UT Southwestern’s Liver Transplant Program produces three-year survival rates that are above the national average.
A Reason to Hope
For Dr. Grant, liver disease represents a complex challenge, as well as an opportunity to help patients with potentially life-threatening conditions.
“Liver disease affects the entire body, so it can be challenging to manage, but that gives me an opportunity to develop long-term relationships with patients,” she says.
Dr. Grant adds that she strives to put herself in her patients’ shoes throughout their treatment journey.
“If I can appreciate it from that perspective, then I think I can do a better job of helping my patients through the process,” she says. “I want to understand how it affects their lives and then help them through that journey.
“I always remember to reassure my patients that the liver is really quite resilient, and we have options for managing their disease.”
Education & Training
Professional Associations & Affiliations
- American Medical Association
- American Gastroenterological Association
- American Association For The Study of Liver Diseases
Honors & Awards
- D Magazine Best Doctor 2022
Books & Publications
-
Publications
-
Acute Liver Failure Guidelines.
Shingina A, Mukhtar N, Wakim-Fleming J, Alqahtani S, Wong RJ, Limketkai BN, Larson AM, Grant L, The American journal of gastroenterology 2023 Jul 118 7 1128-1153 -
Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis.
Schroeder M, Pedersen M, Petrasek J, Grant L, Hepatology communications 2023 May 7 5 -
High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
Rich NE, Parvathaneni A, Sen A, Odewole M, Arroyo A, Mufti AR, Kerr TA, Grant L, Tujios SR, Mayo MJ, Lee WM, Yang JD, Yokoo T, Gopal P, Hoshida Y, Zhu H, Yopp AC, Marrero JA, Singal AG, Digestive diseases and sciences 2021 May -
More Than a Rash: Recurrent Hepatocellular Carcinoma After Liver Transplantation.
Moraveji S, Pedersen MR, Chandramouli S, Kerr TA, Grant LM, ACG case reports journal 2019 Jul 6 7 e00107 -
Two-stage liver transplant for ruptured hepatic adenoma: A case report.
Salhanick M, MacConmara MP, Pedersen MR, Grant L, Hwang CS, Parekh JR, World journal of hepatology 2019 Feb 11 2 242-249 -
Outcomes of simultaneous liver-kidney transplantation: implications for patient selection.
Grant L, Tujios S, Singal AG Current opinion in organ transplantation 2018 Jan -
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R, Hepatology (Baltimore, Md.) 2014 Oct 60 4 1399-408 -
Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide.
Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM Digestive diseases and sciences 2012 Dec -
Drug-induced liver injury.
Grant LM, Rockey DC Current opinion in gastroenterology 2012 May 28 3 198-202 -
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.
Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J Gastroenterology 2006 May 130 6 1564-72 -
Nonalcoholic fatty liver disease.
Grant LM, Lisker-Melman M Annals of hepatology : official journal of the Mexican Association of Hepatology 2004 Jul-Sep 3 3 93-9 -
Treatment of Hepatitis C Virus in the Liver Transplant Recipient.
Grant L, Crippin JS Current treatment options in gastroenterology 2003 Dec 6 6 517-522
-
Acute Liver Failure Guidelines.
Research
- Hepatology
- Gastroenterology
Clinical Focus
- Liver Transplant Evaluations
- Liver Transplant Medicine
- Liver Disease
- Gastroenterology
- Hepatology
Q&A by Dr. Grant
Results: 1 Locations
Professional Office Building 2
5939 Harry Hines Blvd.Dallas, Texas 75390 214-645-8300 Directions to Professional Office Building 2 Parking Info for Professional Office Building 2
New Patient Appointment Accepting Virtual Visits or 214-645-0595